Published in Age Ageing on July 01, 1999
Additional risk factors in atrial fibrillation patients not receiving warfarin. Age Ageing (2000) 0.75
Overlooking orthostatic hypotension with routine blood-pressure equipment. Lancet (1998) 2.03
Activity of temozolomide in the treatment of central nervous system tumor xenografts. Cancer Res (1995) 1.52
Stress-related primary intracerebral hemorrhage: autopsy clues to underlying mechanism. Stroke (2000) 1.44
Discrepancies in the weight of plastic vials. J Clin Pathol (1980) 1.30
Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against pediatric and adult central nervous system tumor xenografts. Cancer Chemother Pharmacol (1997) 1.25
Methylator resistance mediated by mismatch repair deficiency in a glioblastoma multiforme xenograft. Cancer Res (1997) 1.24
Schedule-dependent activity of temozolomide plus CPT-11 against a human central nervous system tumor-derived xenograft. Clin Cancer Res (2000) 1.16
Immunohistochemical co-localization of transient receptor potential vanilloid (TRPV)1 and sensory neuropeptides in the guinea-pig respiratory system. Neuroscience (2006) 1.07
Enhancement of irinotecan (CPT-11) activity against central nervous system tumor xenografts by alkylating agents. Cancer Chemother Pharmacol (1998) 1.00
Activity of 9-dimethylaminomethyl-10-hydroxycamptothecin against pediatric and adult central nervous system tumor xenografts. Cancer Chemother Pharmacol (1994) 1.00
Neuropsychological functioning following fetal striatal transplantation in Huntington's chorea: three case presentations. Cell Transplant (1997) 0.95
Studies on enterovirus in patients with chronic fatigue syndrome. Clin Infect Dis (1994) 0.86
Modulation of cyclophosphamide activity by O6-alkylguanine-DNA alkyltransferase. Cancer Chemother Pharmacol (1999) 0.86
Effects of central muscarinic-1 receptor stimulation on blood pressure regulation. Hypertension (1997) 0.83
Basement membrane proteins in the space of Disse: a reappraisal. J Clin Pathol (1991) 0.83
Acyl derivatives of demethylpenclomedine, an antitumor-active, non-neurotoxic metabolites of penclomedine. Cancer Chemother Pharmacol (2001) 0.81
Association between cognitive impairment and atrial fibrillation: a systematic review. J Stroke Cerebrovasc Dis (2007) 0.81
Busulfan therapy of central nervous system xenografts in athymic mice. Cancer Chemother Pharmacol (1994) 0.80
The 2010 British Association of Stroke Physicians Survey of interventional treatments for stroke in the United Kingdom. Int J Stroke (2013) 0.80
Determination of plasma levels of biliary contrast media. Clin Radiol (1974) 0.79
Therapeutic efficacy of vinorelbine against pediatric and adult central nervous system tumors. Cancer Chemother Pharmacol (1998) 0.78
Investigations to diagnose cause of dizziness in elderly people. Clinical assessment in the surgery is not adequate. BMJ (1997) 0.77
Relation between aortic atherosclerosis and blood pressure. Lancet (1994) 0.75
Enhancement of melphalan activity by inhibition of DNA polymerase-alpha and DNA polymerase-beta. Cancer Chemother Pharmacol (1996) 0.75
Withdrawing cardiovascular medications at a syncope clinic. Postgrad Med J (2001) 0.75
Towards consensus. J Wound Care (1996) 0.75
Prediction of outcome after stroke. Lancet (2001) 0.75
ACE inhibitors and diabetics with albuminuria. Lancet (1995) 0.75
The influence of calciotrophic hormones on lymphocyte transformation and interleukin-2 production in human mononuclear cells. J Clin Lab Immunol (1990) 0.75
Health education. Advice given to coronary patients. Nursing (Lond) (1990) 0.75
Keynote address 2. Canadian National Conference on Occupational Health: Issues and Priorities. Can J Public Health (1977) 0.75
Characterization of the mechanisms of busulfan resistance in a human glioblastoma multiforme xenograft. Cancer Chemother Pharmacol (1997) 0.75
Simplified analytical methods for the measurement of the synthesis rate of plasma proteins in vivo by the [14C]carbonate method. Ann Clin Biochem (1984) 0.75
Engraftment of C6-2B cells into the striatum of ACI nude rats as a tool for comparison of the in vitro and in vivo phenotype of a glioma cell line. Cell Transplant (1997) 0.75